Summit Therapeutics logo

Summit Therapeutics Share Price Today (NASDAQ: SMMT)

Summit Therapeutics share price is 24.87 & ₹2,119.62 as on 15 May 2025, 2.30 'hrs' IST

$24.87

-0.39

(-1.54%)

Live

View live Summit Therapeutics share price in Dollar and Rupees. Guide to invest in Summit Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Summit Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Summit Therapeutics share price movements

  • Today's Low: $24.29
    Today's High: $25.26

    Day's Volatility :3.84%

  • 52 Weeks Low: $2.10
    52 Weeks High: $36.91

    52 Weeks Volatility :94.31%

Summit Therapeutics (SMMT) Returns

PeriodSummit Therapeutics IncSector (Health Care)Index (Russel 2000)
3 Months
32.49%
-7.1%
0.0%
6 Months
21.77%
-7.4%
0.0%
1 Year
426.67%
-5.2%
0.0%
3 Years
2307.62%
5.7%
-1.3%

Summit Therapeutics (SMMT) Key Statistics

in dollars & INR

Previous Close
$25.26
Open
$23.49
Today's High
$25.26
Today's Low
$24.29
Market Capitalization
$17.8B
Today's Volume
$3.0M
52 Week High
$36.91
52 Week Low
$2.1
Revenue TTM
$0.0
EBITDA
$-235.4M
Earnings Per Share (EPS)
$-0.34
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-123.93%

How to invest in Summit Therapeutics Stock (SMMT) from India?

It is very easy for Indian residents to invest directly in Summit Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Summit Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Summit Therapeutics or SMMT on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Summit Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Summit Therapeutics shares which would translate to 0.034 fractional shares of Summit Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Summit Therapeutics, in just a few clicks!

Returns in Summit Therapeutics (SMMT) for Indian investors in Rupees

The Summit Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Summit Therapeutics investment value today

Current value as on today

₹5,33,499

Returns

₹4,33,499

(+433.5%)

Returns from Summit Therapeutics Stock

₹4,31,410 (+431.41%)

Dollar Returns

₹2,089 (+2.09%)

Indian investors sentiment towards Summit Therapeutics (SMMT)

336.84%

Period: Apr 13, 2025 to May 13, 2025. Change in 30 Days versus previous period

Investment in Summit Therapeutics Shares from India has grown by 336.84% over the past 30 days, indicating increased transactional activity.

348%

Period: Apr 13, 2025 to May 13, 2025. Change in 30 Days versus previous period

Search interest for Summit Therapeutics Stock from India on INDmoney has increased by 348% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Summit Therapeutics

  • Polymer Capital Management (Hk) Ltd

    0.03%

Analyst Recommendation on Summit Therapeutics

Rating
Trend

Buy

    85%Buy

    14%Hold

    0%Sell

Based on 7 Wall street analysts offering stock ratings for Summit Therapeutics(by analysts ranked 0 to 5 stars)

Analyst Forecast on Summit Therapeutics Stock (SMMT)

What analysts predicted

Upside of 50.21%

Target:

$37.36

Current:

$24.87

Insights on Summit Therapeutics Stock (Ticker Symbol: SMMT)

  • Price Movement

    In the last 1 year, SMMT stock has moved up by 426.7%
  • Decreasing Revenue

    Revenue is down for the last 3 quarters, 235.0K → -235.0K (in $), with an average decrease of 100.0% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 3 quarters, -56.25M → -62.91M (in $), with an average decrease of 5.8% per quarter

Summit Therapeutics Technicals Summary

Sell

Neutral

Buy

Summit Therapeutics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Summit Therapeutics (SMMT) Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Summit Therapeutics Inc logo
-3.25%
21.77%
426.67%
2307.62%
634.88%
Regeneron Pharmaceuticals, Inc. logo
0.72%
-29.94%
-41.12%
-12.19%
0.76%
Vertex Pharmaceuticals Incorporated logo
-11.36%
-10.31%
2.22%
72.91%
58.66%
Alnylam Pharmaceuticals, Inc. logo
12.33%
0.24%
79.87%
115.9%
97.94%

About Summit Therapeutics

Summit Therapeutics Inc., a biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies. Its lead development candidate is ivonescimab, a bispecific antibody for immunotherapy through blockade of PD-1 with the anti-angiogenesis, as well as in Phase III clinical trials for the treatment of non-small lung cancer. The company was founded in 2003 and is headquartered in Miami, Florida.
Organization
Summit Therapeutics
Employees
159
CEO
Dr. Mahkam Zanganeh D.D.S., M.B.A.
Industry
Health Technology

Management People of Summit Therapeutics

NameTitle
Mr. Robert W. Duggan
Co-CEO & Executive Chairman
Dr. Mahkam Zanganeh D.D.S., M.B.A.
Co-CEO, President & Director
Mr. Manmeet Singh Soni CPA
COO, CFO & Director
Prof. Dame Kay Davies DBE, FRS CBE
Co-Founder, Chairman of Scientific Advisory Board and Scientific Advisor
Mr. Dave Gancarz
Chief Business & Strategy Officer
Dr. Fong Clow
Chief Biometrics Officer
Ms. Shelley D. Spray
Chief Education & Brand Officer
Dr. Urte Gayko Ph.D.
Chief Regulatory, Quality & Pharmacovigilance Officer
Dr. Allen S. Yang M.D., Ph.D.
Chief Medical Officer
Dr. Laura Q. M. Chow M.D.
Senior Vice President of Clinical Development

Important FAQs about investing in SMMT Stock from India :

Can Indians buy Summit Therapeutics shares?

Yes, Indians can invest in the Summit Therapeutics (SMMT) from India.

With INDmoney, you can buy Summit Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Summit Therapeutics at zero transaction cost.

How can I buy Summit Therapeutics shares from India?

It is very easy to buy Summit Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Summit Therapeutics (SMMT) be purchased?

Yes, you can buy fractional shares of Summit Therapeutics with INDmoney app.

What are the documents required to start investing in Summit Therapeutics stocks?

To start investing in Summit Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What is Summit Therapeutics share price today?

Summit Therapeutics share price today stands at $24.87, Open: $23.49 ; Previous Close: $25.26 ; High: $25.26 ; Low: $24.29 ; 52 Week High: $36.91 ; 52 Week Low: $2.10.

The stock opens at $23.49, after a previous close of $25.26. The stock reached a daily high of $25.26 and a low of $24.29, with a 52-week high of $36.91 and a 52-week low of $2.10.

What are today’s High and Low prices of Summit Therapeutics Stock (SMMT)?

Today’s highest price of Summit Therapeutics (SMMT) is $25.26.

Today’s lowest price of Summit Therapeutics (SMMT) is $24.29.

What is the 52 Week High and Low Range of Summit Therapeutics Stock (SMMT)?

  • 52 Week High

    $36.91

  • 52 Week Low

    $2.10

What are the historical returns of Summit Therapeutics (SMMT)?

  • 1 Month Returns

    -3.25%

  • 3 Months Returns

    21.77%

  • 1 Year Returns

    426.67%

  • 5 Years Returns

    634.88%

What is today's market capitalisation of Summit Therapeutics?

Today's market capitalisation of Summit Therapeutics SMMT is 17.8B

Who is the Chief Executive Officer (CEO) of Summit Therapeutics ?

Dr. Mahkam Zanganeh D.D.S., M.B.A. is the current Chief Executive Officer (CEO) of Summit Therapeutics.